Royal Bank of Canada Trims Stake in Addus HomeCare Corporation $ADUS

Royal Bank of Canada lessened its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 32.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 13,744 shares of the company’s stock after selling 6,598 shares during the period. Royal Bank of Canada’s holdings in Addus HomeCare were worth $1,287,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Capital Research Global Investors lifted its position in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after acquiring an additional 10,501 shares during the period. Wasatch Advisors LP lifted its holdings in shares of Addus HomeCare by 0.8% in the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock worth $110,467,000 after acquiring an additional 7,089 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Addus HomeCare by 11.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after acquiring an additional 78,415 shares during the last quarter. Finally, State Street Corp boosted its position in shares of Addus HomeCare by 0.9% during the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock worth $75,412,000 after purchasing an additional 6,561 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

Shares of ADUS opened at $120.55 on Friday. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The firm’s 50 day moving average price is $108.92 and its 200 day moving average price is $102.37. The company has a market cap of $2.25 billion, a P/E ratio of 21.15, a PEG ratio of 1.61 and a beta of 0.87. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million during the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm’s revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.49 EPS. On average, research analysts forecast that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.10% of the company’s stock.

Analyst Ratings Changes

ADUS has been the subject of several research reports. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Citizens Jmp restated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Royal Bank Of Canada boosted their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Finally, Barclays increased their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $130.88.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.